HUT61485A - Process for producing drug composition suitable for treating thrombocytopenia - Google Patents

Process for producing drug composition suitable for treating thrombocytopenia

Info

Publication number
HUT61485A
HUT61485A HU9202026A HU202692A HUT61485A HU T61485 A HUT61485 A HU T61485A HU 9202026 A HU9202026 A HU 9202026A HU 202692 A HU202692 A HU 202692A HU T61485 A HUT61485 A HU T61485A
Authority
HU
Hungary
Prior art keywords
pct
composition suitable
drug composition
producing drug
treating thrombocytopenia
Prior art date
Application number
HU9202026A
Other languages
English (en)
Other versions
HU9202026D0 (en
Inventor
Donald Metcalf
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Publication of HU9202026D0 publication Critical patent/HU9202026D0/hu
Publication of HUT61485A publication Critical patent/HUT61485A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2093—Leukaemia inhibitory factor [LIF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU9202026A 1989-12-18 1990-12-18 Process for producing drug composition suitable for treating thrombocytopenia HUT61485A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPJ791289 1989-12-18
AUPK350190 1990-11-23
PCT/AU1990/000592 WO1991008752A1 (en) 1989-12-18 1990-12-18 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor

Publications (2)

Publication Number Publication Date
HU9202026D0 HU9202026D0 (en) 1992-09-28
HUT61485A true HUT61485A (en) 1993-01-28

Family

ID=25643793

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9202026A HUT61485A (en) 1989-12-18 1990-12-18 Process for producing drug composition suitable for treating thrombocytopenia
HU95P/P00136P HU210882A9 (en) 1989-12-18 1995-05-19 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU95P/P00136P HU210882A9 (en) 1989-12-18 1995-05-19 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor

Country Status (12)

Country Link
US (1) US5571508A (hu)
EP (1) EP0506716B1 (hu)
JP (1) JP2574962B2 (hu)
AT (1) ATE128871T1 (hu)
CA (1) CA2071956C (hu)
DE (1) DE69023006T2 (hu)
DK (1) DK0506716T3 (hu)
ES (1) ES2078501T3 (hu)
FI (1) FI922839A0 (hu)
GR (1) GR3017727T3 (hu)
HU (2) HUT61485A (hu)
WO (1) WO1991008752A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
PL188795B1 (pl) 1995-06-07 2005-04-29 Glaxo Group Ltd Związek wiążący się z receptorem trombopoetyny, kompozycja farmaceutyczna i zastosowanie związku wiążącego się z receptorem trombopoetyny
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
US8067367B2 (en) 2002-09-18 2011-11-29 Janssen Pharmaceutica, N.V. Methods of increasing platelet and hematopoietic stem cell production
US7723295B2 (en) 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
HUE032370T2 (hu) 2003-08-28 2017-09-28 Janssen Pharmaceuticals Inc Trombopoietin receptorokhoz kötõdõ peptidek és vegyületek

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859648A (en) * 1984-12-28 1989-08-22 Mobil Oil Corporation Layered metal chalcogenides containing interspathic polymeric chalcogenides
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
WO1990002183A1 (en) * 1988-08-18 1990-03-08 Genetics Institute, Inc. Production of a novel lymphokine exhibiting differentiation inhibitory activity
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤
DE69027123T2 (de) * 1989-11-24 1997-04-24 Univ Monash Proliferative wirkung des leukämie-hemmungsfaktors auf satellitzellen

Also Published As

Publication number Publication date
ATE128871T1 (de) 1995-10-15
AU644834B2 (en) 1993-12-23
CA2071956C (en) 2000-04-18
FI922839A (fi) 1992-06-17
EP0506716A4 (en) 1993-05-05
US5571508A (en) 1996-11-05
JPH05502667A (ja) 1993-05-13
FI922839A0 (fi) 1992-06-17
EP0506716B1 (en) 1995-10-11
AU6910491A (en) 1991-07-18
WO1991008752A1 (en) 1991-06-27
CA2071956A1 (en) 1991-06-19
JP2574962B2 (ja) 1997-01-22
DE69023006T2 (de) 1996-04-11
EP0506716A1 (en) 1992-10-07
HU210882A9 (en) 1995-09-28
HU9202026D0 (en) 1992-09-28
ES2078501T3 (es) 1995-12-16
GR3017727T3 (en) 1996-01-31
DE69023006D1 (de) 1995-11-16
DK0506716T3 (da) 1996-02-26

Similar Documents

Publication Publication Date Title
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
IL111077A (en) Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them
HU9201883D0 (en) Method for producing peptide derivatives applicable for treatment of glaucoma as well as medical preparatives containing them
FI960102A0 (fi) Uusi farmaseuttinen seos
MD1838F2 (en) 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
HUT61485A (en) Process for producing drug composition suitable for treating thrombocytopenia
GB9410639D0 (en) Method of improving fertilization
EP0649412A4 (en) PYRIDINE PHARMACEUTICAL COMPOUNDS.
GEP20022840B (en) Form VI 5,6-Dichloro-2-(Isopropylamino)-1-(Beta-L-Ribofuranosyl-1H-Benzimidazole), Method for Their Production, Composition for Treating Virus Infections and Methods for Treatment
GR3034142T3 (en) Composition for the treatment or prevention of herpes
HU9201267D0 (en) Method for producing pharmaceutical preparatives containing gfi
ATE121626T1 (de) Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
DE69231583D1 (de) Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.
ES548791A0 (es) Un procedimiento para preparar una sal de metal alcalino o alcalino-terreo de 5-cianopiridin-2-diazohidroxido
AU5625194A (en) Rectal flunisolide compositions for treating inflammatory intestinal disorders
CZ145095A3 (en) Novel triazoloquinazolines, process of their preparation and use
ITMI911016A1 (it) Aminoacil derivati di acidi gem-difosfonici, un processo per la loro preparazione e composizioni farmaceutiche che li contengono
NO922341L (no) Fremgangsmaate og middel for behandling av trombocytopeni
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them
MY102564A (en) An indole derivative

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment